UB Paderborn / Katalog / Suche / in CDI

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Modern pathology, 2019-06, Vol.32 (6), p.741-754

2019

Volltextzugriff (PDF)

Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling

Oncoimmunology, 2017-04, Vol.6 (4), p.e1305535-e1305535

2017

Volltextzugriff (PDF)

Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma

Translational oncology, 2021-03, Vol.14 (3), p.101014-101014, Article 101014

2021

Volltextzugriff (PDF)

CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy

Journal of Immunology, 2007-05, Vol.178 (9), p.5595-5605

2007

Volltextzugriff (PDF)

Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy

The Journal of immunology (1950), 2008-01, Vol.180 (2), p.699-705

2008

Volltextzugriff (PDF)

In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models

Journal of immunotherapy, 2007-10, Vol.30 (7), p.715-726

2007

Volltextzugriff (PDF)

74 Novel approach for profiling immune-tumor cell interactions and mutations in the same tumor section by multiplex immunohistochemistry and NGS in immuno-oncology trials

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A45-A45

2020

Volltextzugriff (PDF)

A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

The Journal of immunology (1950), 2003-04, Vol.170 (8), p.4242-4253

2003

Volltextzugriff (PDF)

Conformational HER-2/neu B-cell Epitope Peptide Vaccine Designed to Incorporate Two Native Disulfide Bonds Enhances Tumor Cell Binding and Antitumor Activities

The Journal of biological chemistry, 2005-01, Vol.280 (1), p.54-63

2005

Volltextzugriff (PDF)

CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non‐Hodgkin lymphoma

Cytometry. Part B, Clinical cytometry, 2012-03, Vol.82B (2), p.112-119

2012

Volltextzugriff (PDF)

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine

Cancer research (Chicago, Ill.), 2000-07, Vol.60 (14), p.3782-3789

2000

Volltextzugriff (PDF)

Abstract 164: Development of DeepCytoFlow: A novel deep learning pipeline enabling automated gating of flow cytometry data

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.164-164

2021

Volltextzugriff (PDF)

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Clinical cancer research, 2018-11, Vol.24 (21), p.5250-5260

2018

Volltextzugriff (PDF)

Abstract 2754: Exploring the interplay between TAM, PD-L1 and immunosuppressive molecules by a novel multiplex immunofluorescence assay in cancer immunotherapy trials

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2754-2754

2021

Volltextzugriff (PDF)

Abstract 4043: Application of high complexity flow cytometry for Monitoring activated T-cells, T and B regulatory subsets in combination immunotherapy trials, melanoma case study

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4043-4043

2019

Volltextzugriff (PDF)

Synthetic peptides as cancer vaccines

Biopolymers, 2002, Vol.66 (3), p.200-216

2002

Volltextzugriff (PDF)

Monitoring CAR‐T cell kinetics in clinical trials by multiparametric flow cytometry: Benefits and challenges

Cytometry. Part B, Clinical cytometry, 2021-01, Vol.100 (1), p.72-78

2021

Volltextzugriff (PDF)

Abstract 6193: Exploring interplay between tumor intrinsic features and immune cell phenotypes in multi-tumor tissue microarrays by a single step 15-plex fluorescence immunohistochemistry and imaging on the Orion platform

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6193-6193

2024

Volltextzugriff (PDF)

Abstract 6424: A patient centric full spectrum flow cytometry assay for comprehensive phenotyping of CAR T cells in clinical trials

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6424-6424

2024

Volltextzugriff (PDF)

Abstract 6409: A multiparametric flow cytometry assay to monitor regeneration of B-cells following anti B-cell therapy in cancer and autoimmune patients

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6409-6409

2024

Volltextzugriff (PDF)

Recommendations for clinical biomarker specimen preservation and stability assessments

Bioanalysis, 2017-04, Vol.9 (8), p.643-653

2017

Volltextzugriff (PDF)

Predictive value of circulating B cells and T cell subsets in melanoma patients treated with neoadjuvant ipilimumab and interferon

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15036-e15036

2020

Volltextzugriff (PDF)

Predictive evaluation of quantitative spatial profiling of the tumor microenvironment by multiplex immunofluorescence in recurrent glioblastoma treated with PD-1 inhibitors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e14524-e14524

2020

Volltextzugriff (PDF)

Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial

Leukemia research, 2020-01, Vol.88, p.106283-106283, Article 106283

2020

Volltextzugriff (PDF)

Abstract 6615: Novel digital pathology tools for exploring role of myeloid cells in modulating next generation immunotherapies

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6615-6615

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling

Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma

CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy

Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy

In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models

74 Novel approach for profiling immune-tumor cell interactions and mutations in the same tumor section by multiplex immunohistochemistry and NGS in immuno-oncology trials

A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

Conformational HER-2/neu B-cell Epitope Peptide Vaccine Designed to Incorporate Two Native Disulfide Bonds Enhances Tumor Cell Binding and Antitumor Activities

CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non‐Hodgkin lymphoma

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine

Abstract 164: Development of DeepCytoFlow: A novel deep learning pipeline enabling automated gating of flow cytometry data

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Abstract 2754: Exploring the interplay between TAM, PD-L1 and immunosuppressive molecules by a novel multiplex immunofluorescence assay in cancer immunotherapy trials

Abstract 4043: Application of high complexity flow cytometry for Monitoring activated T-cells, T and B regulatory subsets in combination immunotherapy trials, melanoma case study

Synthetic peptides as cancer vaccines

Monitoring CAR‐T cell kinetics in clinical trials by multiparametric flow cytometry: Benefits and challenges

Abstract 6193: Exploring interplay between tumor intrinsic features and immune cell phenotypes in multi-tumor tissue microarrays by a single step 15-plex fluorescence immunohistochemistry and imaging on the Orion platform

Abstract 6424: A patient centric full spectrum flow cytometry assay for comprehensive phenotyping of CAR T cells in clinical trials

Abstract 6409: A multiparametric flow cytometry assay to monitor regeneration of B-cells following anti B-cell therapy in cancer and autoimmune patients

Recommendations for clinical biomarker specimen preservation and stability assessments

Predictive value of circulating B cells and T cell subsets in melanoma patients treated with neoadjuvant ipilimumab and interferon

Predictive evaluation of quantitative spatial profiling of the tumor microenvironment by multiplex immunofluorescence in recurrent glioblastoma treated with PD-1 inhibitors

Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial

Abstract 6615: Novel digital pathology tools for exploring role of myeloid cells in modulating next generation immunotherapies

Suchergebnisse filtern